Neurology®
The most widely read and highly cited peer-reviewed Neurology journal
Quick Search
Advanced Search
Published online before print November 18, 2009, doi:10.1212/WNL.0b013e3181c3f27d)
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow CME: Take the course for this article:
Volume 73, Number 22, December 1, 2009
Right arrow All Versions of this Article:
WNL.0b013e3181c3f27dv1
73/22/1831    most recent
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Google Scholar
Right arrow Articles by Kelly, V. M.
Right arrow Articles by Chakravarty, E. F.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kelly, V. M.
Right arrow Articles by Chakravarty, E. F.
Related Collections
Right arrow Outcome research
Right arrow Autoimmune diseases
Right arrow Multiple sclerosis
Right arrow All epidemiology
Right arrow All Epilepsy/Seizures
Right arrowRelated Article
NEUROLOGY 2009;73:1831-1836
© 2009 American Academy of Neurology

Obstetric outcomes in women with multiple sclerosis and epilepsy

Victoria M. Kelly, MD, Lorene M. Nelson, PhD, MS and Eliza F. Chakravarty, MD, MS

From the Department of Medicine (V.M.K.), Division of Epidemiology, Department of Health Research and Policy (L.M.N.), and Division of Immunology and Rheumatology, Department of Medicine (E.F.C.), Stanford University School of Medicine, Stanford, CA.

Address correspondence and reprint requests to Dr. Eliza F. Chakravarty, 1000 Welch Road, Ste. 230, MC 5755, Stanford, CA 94304; echakravarty{at}stanford.edu

Objective: To estimate the national occurrence of pregnancies in women with multiple sclerosis (MS) and epilepsy and to compare these pregnancy outcomes cross-sectionally with those in women with pregestational diabetes mellitus (DM) and the general obstetric population.

Methods: We studied the 2003–2006 Nationwide Inpatient Sample, of the Healthcare Cost and Utilization Project, to estimate the number of deliveries in women with MS, epilepsy, DM, and the general obstetric population. Pregnancy outcomes included length of hospital stay, hypertensive disorders including preeclampsia (HTN), premature rupture of membranes (PROM), intrauterine growth restriction (IUGR), and cesarean delivery. Multivariable regression analyses used maternal age and race/ethnicity as covariates.

Results: Of an estimated 18.8 million deliveries, 10,055 occurred in women with MS, 4,730 with epilepsy, and 187,239 with DM. MS was associated with mildly increased odds of antenatal hospitalization (odds ratio [OR] 1.3, 95% confidence interval [CI] 1.2–1.5), IUGR (OR 1.7, 95% CI 1.2–2.4), and cesarean delivery (OR 1.3, 95% CI 1.1–1.4). Similarly, epilepsy was associated with increased rates of antenatal hospitalization (OR 3.0, 95% CI 2.6–3.5), IUGR (OR 1.9, 95% CI 1.2–3.3), and cesarean delivery (OR 1.5, 95% CI 1.3–1.9). HTN and PROM were not increased in either group. DM was associated with an increased risk of all adverse outcomes. Length of stay was modestly increased in all groups compared with controls.

Conclusion: In this large national database study of pregnancy outcomes in women with multiple sclerosis and epilepsy, rates of intrauterine growth restriction and cesarean delivery were only marginally higher than the general obstetric population without increases in other adverse outcomes.

Abbreviations: AED = antiepileptic drug; CI = confidence interval; DM = diabetes mellitus; HTN = hypertensive disorders including preeclampsia; ICD-9-CM = International Classification of Diseases, Ninth Revision, Clinical Modification; IUGR = intrauterine growth restriction; LOS = length of hospital stay; MS = multiple sclerosis; NIS = Nationwide Inpatient Sample; OR = odds ratio; PROM = premature rupture of membranes.


Editorial, page 1820

e-Pub ahead of print on November 18, 2009, at www.neurology.org.

Disclosure: Author disclosures are provided at the end of the article.

Received April 12, 2009. Accepted in final form August 20, 2009.


Related Article

Multiple sclerosis and pregnancy: What should we be telling our patients?
Gary M. Franklin and Helen Tremlett
Neurology 2009 73: 1820-1822. [Full Text] [PDF]



This article has been cited by other articles:


Home page
JWatch NeurologyHome page
Pregnancy and Childbirth in Women with MS
Journal Watch Neurology, February 9, 2010; 2010(209): 1 - 1.
[Full Text]


Home page
NeurologyHome page
G. M. Franklin and H. Tremlett
Multiple sclerosis and pregnancy: What should we be telling our patients?
Neurology, December 1, 2009; 73(22): 1820 - 1822.
[Full Text] [PDF]